C-POST Protocol Update: A Phase 3, Randomized, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo Post Surgery and Radiation Therapy in Patients With High-Risk Cutaneous Squamous Cell Carcinoma. J of Skin 2023, 7 (2), s173. https://doi.org/10.25251/skin.7.supp.173.